Hong Kong: Becoming a Biotech Funding Hub
2018 marked a significant milestone in Hong Kong’s journey towards creating a vibrant biotech market for investors which allows Asian innovation to receive the funding it needs to progress. It…
MediConcepts was founded with the aim to provide the optimized solutions for medical device design development and manufacturing to a wide range of customers whether they are innovators who need a compliant product development process and collaboration; or projects seeking for a reliable high quality mass production with complete traceability.
Early projects that MediConcepts encountered include redeveloping a two hand operated intra-ocular lens disposable case to an one hand operated casing in late 90’s; and a minimal invasive tissue retrieval system originated from a UK surgeon who is also a pioneer in minimal access surgery in early 2000’s. The design briefs were simply a hand-sketched drawing faxed to us and we delivered a complete design and production in less than 6 months. Since then, our philosophy has been focusing on “design by surgeon for surgeons” medical devices.
The range of products that we now cover are very broad. “Think Medical” is our believe and “Redefine the medical device Contract Manufacturing Experience” is what we want to offer to our customers. Eventually, we want to position MC to be the ideal CM.
Contact
Address 7A-D Hong Kong Industrial Building, 444-452 Des Voeux Road West, Hong Kong
Tel: +852 2838 0300
Website: http://www.mediconcepts.com/
Email: marketing@mediconcepts.com
2018 marked a significant milestone in Hong Kong’s journey towards creating a vibrant biotech market for investors which allows Asian innovation to receive the funding it needs to progress. It…
Insighta, formed this year as a 50/50 joint venture between genomics-focused outfit Prenetics and one of the city’s most feted scientific sons, Professor Dennis Lo, is aiming to change the…
Almost a decade on from the establishment of a Phase I clinical trial centre in Hong Kong, the city continues to pursue a stronger positioning within the global clinical research…
Albert Wong of the Hong Kong Science and Technology Parks Corporation (HKSTP) outlines how Hong Kong has developed as an innovation hub, building on its established areas of finance and…
Novartis, one of the world’s largest biopharma companies, has secured approval and market access for two of its most advanced cell and gene treatments in Hong Kong. The firm’s territory…
Generative Artificial Intelligence (AI) has grabbed a lot of media attention in recent months following the launch of chatbot ChatGPT, but the pharmaceutical industry has long been trying – and…
One of Asia’s most pre-eminent oncologists, Professor Tony Mok is perhaps best known for discovering the EGFR mutation gene and subsequently developing a targeted therapy that is more precise and…
Established in 2017 as a spin-off from Lee’s Pharmaceutical, Zhaoke Ophthalmology is aiming to be a global player in the ophthalmology field, building on its strong footprint in China and…
Serial entrepreneur Danny Yeung highlights the work of his Hong Kong-based genomics-driven firm Prenetics in prevention, early detection and targeted therapy. Having recently announced a USD 200 million joint venture…
Since first allowing pre-revenue biotechs to list in 2018, the Hong Kong stock exchange has welcomed 59 such companies and is now a leading vehicle for allowing Chinese biopharma to…
The Hong Kong Association of the Pharmaceutical Industry (HKAPI) represents the interests of the global R&D-based biopharmaceutical industry in Hong Kong and Macau. Senior Executive Director Sabrina Chan outlines the…
AstraZeneca, the largest overseas pharmaceutical company in mainland China by sales, is also the market leader in Hong Kong and Macau, a territory overseen by General Manager Shan Wu. She…
See our Cookie Privacy Policy Here
